Inhibikase Therapeutics News

Buy Rating Affirmed for Inhibikase Therapeutics Amid Clinical Advancements and Regulatory Progress

TipRanksApr 3 03:15

Inhibikase Therapeutics Analyst Ratings

BenzingaMar 8 00:24

Inhibikase Therapeutics Analyst Ratings

BenzingaMar 5 23:49

Inhibikase Therapeutics: Buy Rating Affirmed Amid Promising Drug Candidates and Strong Financial Standing

TipRanksFeb 21 21:36

Maxim Initiates Inhibikase Therapeutics With Buy Rating, Price Target Is $8

MT NewswiresFeb 21 00:11

Promising Developments and Financial Outlook for Inhibikase Therapeutics Prompt Buy Rating

TipRanksOct 4, 2023 22:15

Inhibikase Therapeutics (IKT) Gets a Hold From JonesTrading

TipRanksAug 19, 2023 04:25

Inhibikase Therapeutics Analyst Ratings

BenzingaAug 15, 2023 23:50

H.C. Wainwright Remains a Buy on Inhibikase Therapeutics (IKT)

TipRanksAug 15, 2023 22:35

HC Wainwright & Co. Maintains Buy on Inhibikase Therapeutics, Raises Price Target to $27

BenzingaJul 1, 2023 00:24

H.C. Wainwright Keeps Their Buy Rating on Inhibikase Therapeutics (IKT)

TipRanksJun 30, 2023 22:05

Inhibikase Therapeutics (IKT) Receives a Buy From H.C. Wainwright

TipRanksJun 22, 2023 22:25

H.C. Wainwright Keeps Their Buy Rating on Inhibikase Therapeutics (IKT)

TipRanksMay 16, 2023 22:55

JonesTrading Reaffirms Their Hold Rating on Inhibikase Therapeutics (IKT)

TipRanksApr 29, 2023 04:11

Analysts Offer Insights on Healthcare Companies: Inhibikase Therapeutics (IKT) and Blue Water Vaccines, Inc. (BWV)

TipRanksApr 26, 2023 22:11

HC Wainwright & Co. Initiates Coverage On Inhibikase Therapeutics With Buy Rating, Announces Price Target of $5

BenzingaApr 18, 2023 18:20

Analysts Have Conflicting Sentiments on These Healthcare Companies: Moderna (MRNA) and Inhibikase Therapeutics (IKT)

TipRanksDec 9, 2022 02:05

Analysts Offer Insights on Healthcare Companies: Moderna (MRNA), Inozyme Pharma (INZY) and Inhibikase Therapeutics (IKT)

TipRanksDec 9, 2022 02:05